arrow
F

Flavia Foca

irccs istituto romagnolo per lo studio dei tumori irst dino amadori
H指数:27
被引数:2,092

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy

基线血清癌胚抗原(CEA)是接受177Lu-PSMA治疗的转移性去势抵抗性前列腺癌(mCRPC)患者的独立预后生物标志物

2026-09-110
OAAI
DLL3 expression in neuroendocrine carcinomas: a comparative analysis across tumor origins

神经内分泌癌中DLL3的表达:基于肿瘤起源的比较分析

2026-08-120
OA
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysis

人工智能预测三阴性乳腺癌新辅助治疗病理完全缓解:一项系统评价和荟萃分析

2026-07-020
OA
CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine

CORSA研究发现在淋巴瘤患者接种SARS-CoV-2疫苗后出现针对刺突蛋白的免疫应答减弱现象

2026-05-200
OAAI
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study

177Lu-PSMA-617放射性配体疗法的疗效、毒性和临床结局:一项前瞻性、单臂、II期研究,研究对象为每周期接受5.5 GBq剂量的晚期去势抵抗性前列腺癌患者

2025-11-270
OAAI
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas
2024-09-012
OAAI
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
2024-08-133
OAAI
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)
2024-03-273
OAAI
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series
2023-08-167
OAAI
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors
2023-01-203
OAAI
Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study
2022-04-0830
OAAI